These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

925 related items for PubMed ID: 29095069

  • 1. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder.
    Hood SD, Broyd A, Robinson H, Lee J, Hudaib AR, Hince DA.
    J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069
    [Abstract] [Full Text] [Related]

  • 2. Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorder.
    Hood SD, Hince DA, Davies SJ, Argyropoulos S, Robinson H, Potokar J, Nutt DJ.
    Psychopharmacology (Berl); 2010 Feb; 208(2):223-32. PubMed ID: 19936713
    [Abstract] [Full Text] [Related]

  • 3. Lack of effects on core obsessive-compulsive symptoms of tryptophan depletion during symptom provocation in remitted obsessive-compulsive disorder patients.
    Berney A, Sookman D, Leyton M, Young SN, Benkelfat C.
    Biol Psychiatry; 2006 May 01; 59(9):853-7. PubMed ID: 16213470
    [Abstract] [Full Text] [Related]

  • 4. Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors.
    Barr LC, Goodman WK, McDougle CJ, Delgado PL, Heninger GR, Charney DS, Price LH.
    Arch Gen Psychiatry; 1994 Apr 01; 51(4):309-17. PubMed ID: 8161291
    [Abstract] [Full Text] [Related]

  • 5. Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder.
    Argyropoulos SV, Hood SD, Adrover M, Bell CJ, Rich AS, Nash JR, Rich NC, Witchel HJ, Nutt DJ.
    Biol Psychiatry; 2004 Oct 01; 56(7):503-9. PubMed ID: 15450786
    [Abstract] [Full Text] [Related]

  • 6. Effects of tryptophan depletion on cognitive functioning, obsessive-compulsive symptoms and mood in obsessive-compulsive disorder: preliminary results.
    Külz AK, Meinzer S, Kopasz M, Voderholzer U.
    Neuropsychobiology; 2007 Oct 01; 56(2-3):127-31. PubMed ID: 18259085
    [Abstract] [Full Text] [Related]

  • 7. Serotonin and sensitivity to trauma-related exposure in selective serotonin reuptake inhibitors-recovered posttraumatic stress disorder.
    Corchs F, Nutt DJ, Hood S, Bernik M.
    Biol Psychiatry; 2009 Jul 01; 66(1):17-24. PubMed ID: 19268914
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS.
    Arch Gen Psychiatry; 1990 Jun 01; 47(6):577-85. PubMed ID: 2112374
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
    Gosmann NP, Costa MA, Jaeger MB, Motta LS, Frozi J, Spanemberg L, Manfro GG, Cuijpers P, Pine DS, Salum GA.
    PLoS Med; 2021 Jun 01; 18(6):e1003664. PubMed ID: 34111122
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.
    March JS, Biederman J, Wolkow R, Safferman A, Mardekian J, Cook EH, Cutler NR, Dominguez R, Ferguson J, Muller B, Riesenberg R, Rosenthal M, Sallee FR, Wagner KD, Steiner H.
    JAMA; 1998 Nov 25; 280(20):1752-6. PubMed ID: 9842950
    [Abstract] [Full Text] [Related]

  • 17. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.
    Weiss EL, Potenza MN, McDougle CJ, Epperson CN.
    J Clin Psychiatry; 1999 Aug 25; 60(8):524-7. PubMed ID: 10485634
    [Abstract] [Full Text] [Related]

  • 18. Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials.
    Dold M, Aigner M, Lanzenberger R, Kasper S.
    Int J Neuropsychopharmacol; 2015 May 04; 18(9):. PubMed ID: 25939614
    [Abstract] [Full Text] [Related]

  • 19. Risperidone and haloperidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder: a crossover study.
    Li X, May RS, Tolbert LC, Jackson WT, Flournoy JM, Baxter LR.
    J Clin Psychiatry; 2005 Jun 04; 66(6):736-43. PubMed ID: 15960567
    [Abstract] [Full Text] [Related]

  • 20. Depleting serotonin enhances both cardiovascular and psychological stress reactivity in recovered patients with anxiety disorders.
    Davies SJ, Hood SD, Argyropoulos SV, Morris K, Bell C, Witchel HJ, Jackson PR, Nutt DJ, Potokar JP.
    J Clin Psychopharmacol; 2006 Aug 04; 26(4):414-8. PubMed ID: 16855462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.